Urinary Tract Infection (Enterococcus faecium/faecalis)
Overview
Plain-Language Overview
Urinary Tract Infection (Enterococcus faecium/faecalis) is an infection that affects the urinary system, which includes the kidneys, bladder, and urethra. It is caused by bacteria called Enterococcus faecium or Enterococcus faecalis. These bacteria can enter the urinary tract and cause symptoms like painful urination, frequent urge to urinate, and lower abdominal discomfort. The infection can sometimes lead to more serious problems if it spreads to the kidneys or bloodstream. Early recognition and diagnosis are important to prevent complications. This condition mainly affects the bladder and urethra, but can involve the entire urinary tract.
Clinical Definition
Urinary Tract Infection (Enterococcus faecium/faecalis) is defined as a bacterial infection of any part of the urinary tract caused by the gram-positive cocci Enterococcus faecium or Enterococcus faecalis. These organisms are part of the normal intestinal flora but can become pathogenic when introduced into the urinary tract, often via catheterization or instrumentation. The infection results in inflammation of the urinary epithelium, leading to symptoms such as dysuria, urgency, and frequency. Enterococcal UTIs are clinically significant due to their intrinsic resistance to many antibiotics and their association with complicated infections, especially in hospitalized or immunocompromised patients. They can cause cystitis, pyelonephritis, and in severe cases, bacteremia. Diagnosis and management require awareness of their unique resistance patterns and potential for nosocomial spread.
Inciting Event
Insertion of a urinary catheter introduces bacteria and disrupts mucosal barriers.
Recent antibiotic therapy that alters normal genitourinary flora favoring Enterococcus overgrowth.
Urologic instrumentation or surgery breaches mucosal defenses and facilitates bacterial entry.
Urinary retention or obstruction leading to stasis and bacterial proliferation.
Latency Period
Symptoms typically develop within days after catheter insertion or urologic manipulation.
In community-acquired cases, symptom onset is usually acute within 1-3 days of bacterial colonization.
Chronic catheter-associated infections may have a more insidious onset over weeks.
Diagnostic Delay
Atypical presentation in elderly or immunocompromised patients can delay recognition.
Misattribution of symptoms to other causes such as dehydration or medication side effects.
Negative or mixed urine cultures due to prior antibiotic use or contamination.
Assuming Enterococcus is a contaminant rather than a pathogen in urine cultures.
Clinical Presentation
Signs & Symptoms
Dysuria, urinary frequency, and urgency are hallmark symptoms.
Suprapubic pain and lower abdominal discomfort are common.
Fever and chills may indicate upper tract involvement or systemic infection.
Cloudy or foul-smelling urine can be present but is nonspecific.
History of Present Illness
Dysuria, urinary frequency, and urgency are common initial symptoms.
Suprapubic pain or discomfort may be reported with lower urinary tract involvement.
Fever and chills suggest progression to upper urinary tract infection or bacteremia.
In catheterized patients, cloudy or foul-smelling urine and catheter malfunction are typical.
Symptoms may be subtle or absent in elderly or immunosuppressed patients.
Past Medical History
History of recurrent urinary tract infections increases risk of resistant Enterococcus infection.
Previous urinary catheterization or urologic procedures predispose to infection.
Chronic kidney disease or urinary tract abnormalities contribute to susceptibility.
Recent hospitalization or antibiotic exposure selects for resistant organisms.
Family History
[]
Physical Exam Findings
Suprapubic tenderness on palpation indicating bladder inflammation.
Costovertebral angle tenderness suggesting upper urinary tract involvement.
Fever may be present in complicated or pyelonephritis cases.
Tachycardia and signs of systemic infection in severe cases.
Diagnostic Workup
Diagnostic Criteria
Diagnosis of urinary tract infection caused by Enterococcus faecium or Enterococcus faecalis is established by a combination of clinical symptoms such as dysuria, urgency, and frequency, along with laboratory confirmation. The key diagnostic test is a urine culture demonstrating significant growth of Enterococcus species, typically ≥10^5 colony-forming units per milliliter in a clean-catch specimen. Urinalysis often shows pyuria and may reveal bacteriuria. Identification of the organism and antibiotic susceptibility testing are essential due to frequent resistance. Imaging is reserved for complicated cases or suspected upper tract involvement.
Pathophysiology
Key Mechanisms
Colonization of the urinary tract by Enterococcus faecium or faecalis through ascending infection from the periurethral area.
Biofilm formation on urinary catheters or uroepithelium facilitating bacterial persistence and antibiotic resistance.
Adherence to uroepithelial cells via surface adhesins promoting mucosal invasion.
Resistance to host immune defenses and intrinsic resistance to many antibiotics complicate eradication.
Inflammatory response triggered by bacterial invasion causing urinary tract epithelial damage and symptoms.
| Involvement | Details |
|---|---|
| Organs | Bladder is the main organ affected in lower urinary tract infections caused by Enterococcus faecium or faecalis, presenting with dysuria and frequency. |
Kidneys may be involved in ascending infection leading to pyelonephritis, which can cause flank pain and systemic symptoms. | |
| Tissues | Urothelium lines the urinary tract and serves as the primary site of bacterial adherence and invasion in urinary tract infections. |
Bladder mucosa becomes inflamed during infection, leading to symptoms of cystitis such as pain and urgency. | |
| Cells | Neutrophils are the primary immune cells that infiltrate the urinary tract to phagocytose Enterococcus bacteria during infection. |
Macrophages contribute to bacterial clearance and release cytokines that amplify the inflammatory response in urinary tract infection. | |
Urothelial cells act as a barrier and participate in immune signaling during infection with Enterococcus faecium or faecalis. | |
| Chemical Mediators | Interleukin-8 (IL-8) recruits neutrophils to the site of urinary tract infection, enhancing bacterial clearance. |
Tumor necrosis factor-alpha (TNF-α) promotes inflammation and helps coordinate the immune response against Enterococcus. | |
Prostaglandins mediate local inflammation and contribute to symptoms such as dysuria and urgency. |
Treatments
Pharmacological Treatments
Ampicillin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis.
- Side effects:
Allergic reactions
Gastrointestinal upset
Rash
- Clinical role:
First-line
Vancomycin
- Mechanism:
Inhibits bacterial cell wall synthesis by binding to D-Ala-D-Ala terminus of cell wall precursors, effective against resistant strains.
- Side effects:
Nephrotoxicity
Ototoxicity
Red man syndrome
- Clinical role:
Second-line
Linezolid
- Mechanism:
Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, effective against multidrug-resistant Enterococcus.
- Side effects:
Bone marrow suppression
Peripheral neuropathy
Serotonin syndrome
- Clinical role:
Second-line
Nitrofurantoin
- Mechanism:
Damages bacterial DNA after enzymatic reduction, effective for lower urinary tract infections.
- Side effects:
Pulmonary toxicity
Hemolytic anemia in G6PD deficiency
Gastrointestinal upset
- Clinical role:
First-line for uncomplicated cystitis
Non-pharmacological Treatments
Ensure adequate hydration to promote urinary flow and bacterial clearance.
Use urinary catheterization only when necessary to reduce risk of infection.
Implement proper perineal hygiene to prevent bacterial colonization.
Prevention
Pharmacological Prevention
Low-dose prophylactic antibiotics in patients with recurrent UTIs, tailored to susceptibility.
Use of agents effective against Enterococcus, such as ampicillin or vancomycin for resistant strains.
Avoidance of broad-spectrum antibiotics that promote resistant Enterococcus colonization.
Non-pharmacological Prevention
Proper catheter care and timely removal to reduce infection risk.
Adequate hydration to promote urinary flow and clearance of bacteria.
Addressing urinary obstruction through surgical or medical management.
Good perineal hygiene to reduce bacterial colonization.
Outcome & Complications
Complications
Pyelonephritis from ascending infection.
Perinephric abscess formation in severe cases.
Urosepsis leading to systemic inflammatory response and organ dysfunction.
Infective endocarditis especially in patients with bacteremia and cardiac risk factors.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Urinary Tract Infection (Enterococcus faecium/faecalis) versus Escherichia coli Urinary Tract Infection
Urinary Tract Infection (Enterococcus faecium/faecalis) | Escherichia coli Urinary Tract Infection |
|---|---|
Enterococcus faecium/faecalis are gram-positive cocci often associated with healthcare-associated UTI | Escherichia coli is a gram-negative rod and the most common cause of community-acquired UTI |
Often occurs after recent hospitalization, catheter use, or antibiotic exposure | Community-acquired infection without recent hospitalization or catheterization |
Frequently resistant to multiple antibiotics, requiring vancomycin or linezolid | Typically sensitive to first-line antibiotics like nitrofurantoin or trimethoprim-sulfamethoxazole |
Urinary Tract Infection (Enterococcus faecium/faecalis) versus Candida Urinary Tract Infection
Urinary Tract Infection (Enterococcus faecium/faecalis) | Candida Urinary Tract Infection |
|---|---|
Enterococcus species are gram-positive cocci causing bacterial UTI | Candida species are yeast and cause fungal UTI |
Often associated with recent hospitalization and antibiotic use but less commonly immunosuppressed | Common in immunocompromised patients or those with indwelling catheters and broad-spectrum antibiotics |
Urine culture grows gram-positive cocci in chains or pairs | Urine culture grows yeast with pseudohyphae on microscopy |
Urinary Tract Infection (Enterococcus faecium/faecalis) versus Proteus mirabilis Urinary Tract Infection
Urinary Tract Infection (Enterococcus faecium/faecalis) | Proteus mirabilis Urinary Tract Infection |
|---|---|
Enterococcus species are gram-positive cocci without urease activity | Proteus mirabilis is a gram-negative rod known for urease production |
Urine pH is typically normal or acidic without urease activity | Urine pH is alkaline due to urease activity causing struvite stones |
Usually no stone formation associated | May show renal or bladder calculi on imaging due to stone formation |
Urinary Tract Infection (Enterococcus faecium/faecalis) versus Klebsiella pneumoniae Urinary Tract Infection
Urinary Tract Infection (Enterococcus faecium/faecalis) | Klebsiella pneumoniae Urinary Tract Infection |
|---|---|
Enterococcus species are gram-positive cocci without a capsule | Klebsiella pneumoniae is a gram-negative encapsulated rod |
More commonly associated with healthcare exposure and catheterization | Often causes UTI in patients with diabetes or urinary tract abnormalities |
Often resistant to cephalosporins, requiring glycopeptides or linezolid | May respond to cephalosporins unless ESBL-producing |
Urinary Tract Infection (Enterococcus faecium/faecalis) versus Staphylococcus saprophyticus Urinary Tract Infection
Urinary Tract Infection (Enterococcus faecium/faecalis) | Staphylococcus saprophyticus Urinary Tract Infection |
|---|---|
Enterococcus species are gram-positive cocci but catalase-negative | Staphylococcus saprophyticus is a coagulase-negative gram-positive coccus |
Can affect a broader age range, often hospitalized or catheterized patients | Commonly affects young sexually active women |
Often resistant to these agents, requiring vancomycin or linezolid | Usually sensitive to nitrofurantoin and trimethoprim-sulfamethoxazole |